All In MedTech

Device Trial Radar · NCT06944639

Comparative Study of Three Collagen Membranes: 1 Non-cross-linked and 2 Cross-linked

Comparative Analysis of Three Types of Collagen Membranes Exposed to the Oral Environment: a Randomized Clinical Trial

Last checked: Nov 20, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

25

Actual

Start

Apr 28, 2025

Primary completion

Jun 25, 2026

Study completion Jun 25, 2026

Sponsor

Lead sponsor
Andrea RavidaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Dentsply Sirona Inc.
First posted
Apr 25, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is being done to compare how quickly three different types of collagen membranes break down when they are exposed to the mouth. These membranes are often used in dental and oral surgery to help with healing and tissue growth. The goal is to find out if one membrane lasts longer than the others, which may help doctors choose the best option for different procedures. In this study, the membranes will be placed in the mouth in a specific area near the gums of the upper back teeth. The study is designed so that neither the patients nor the researchers evaluating the results will know which membrane is which (this is called a double-blind study). Over time, researchers will measure how much each membrane has broken down. This information may help improve treatment planning and patient outcomes in dental care.

Conditions

  • Bone Regeneration

Interventions

  • Membrane Jason MB GmbH Non-cross-linked (NCL)Device

    The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

  • Membrane BioMend Extend Glutaraldehyde cross-linkedDevice

    The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

  • Membrane OSSIX Agile Ribose cross-linked (RCL)Device

    The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Degradation rates of three different collagen membranes simulating exposure to the oral environment.Time frame: 10 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Pittsburgh, School of Dental Medicine

    Pittsburgh, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.